List of Contents

Medical Affairs Outsourcing Market Size, Share, and Trends 2025 to 2034

The global medical affairs outsourcing market size is evaluated at USD 2.08 billion in 2025 and is forecasted to hit around USD 3.89 billion by 2034, growing at a CAGR of 7.18% from 2025 to 2034. The North America market size was accounted at USD 710 million in 2024 and is expanding at a CAGR of 6.64% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : 04 Mar 2025
  • Report Code : 1113
  • Category : Healthcare

Medical Affairs Outsourcing Market Size and Forecast 2025 to 2034

The global medical affairs outsourcing market size accounted for USD 1.95 billion in 2024 and is predicted to increase from USD 2.08 billion in 2025 to approximately USD 3.89 billion by 2034, expanding at a CAGR of 7.18% from 2025 to 2034.

Medical Affairs Outsourcing Market Size 2025 to 2034

Medical Affairs Outsourcing Market Key Takeaways

  • North America region was valued at USD 710 million in 2024.
  • By Industry, the pharmaceutical segment was valued at USD 1,029.61 million in 2024. 
  • By Services, the medical writing & publishing segment reached USD 654.62 million in 2024.

U.S. Medical Affairs Outsourcing Market Size and Growth 2025 to 2034

The U.S. medical affairs outsourcing market size was exhibited at USD 580 million in 2024 and is projected to be worth around USD 1,150 million by 2034, growing at a CAGR of 7.05% from 2025 to 2034.

U.S. Medical Affairs Outsourcing Market Size 2025 to 2034

North America region emerged as most dominating market place for the medical affairs outsourcing business in 2024 an estimated to mirror this predominance the period. Reasons such as vigorous FDA supervisors, existence of international life sciences and pharmaceutical giants and availability of talent pool are prospering the growth of the market in this region. The mounting figures of patent expirations along with escalating spending of research and development undertakings are some of the crucial factors persuading the event of the global medical affairs outsourcing market.

Medical Affairs Outsourcing Market Share, By Region, 2024 (%)

As rivalry in the international medical device market exaggerates, the U.S. medical businesses are progressively looking for means to decrease costs in manufacturing, clinical trials, research and development, and other medical services. Numerous Asian nationsbid a lower charge of labor such as China and India and skillful labor force. Merging this with the region’s fast-growing markets and growing mature populations propose encouraging openings for the U.S. medical device corporations outsourcing their affairs to Asia Pacific. For instance, at present elderly population in Japan is around 20% against 12% aged population in the U.S.

  • North America reached USD 706.61 million in 2024 and is anticipated to reach USD 1,342.31 million by 2034, registering a CAGR of 6.64% from 2025 to 2034.
  • Asia Pacific was valued at USD 647.55 million in 2024 and is expected to reach USD 1,473.76 million by 2034, with a CAGR of 8.57% from 2025 to 2034.
  • Europe was reached at USD 370.42 million in 2024 and is anticipated to reach USD 642.74 million by 2034, registering a CAGR of 5.68% from 2025 to 2034.

Medical Affairs Outsourcing Market Growth Factors

Current trends display an upsurge in subcontracting vital functional accomplishments predominantly in medical affairs including medical material, field-based medical teams and medical publications. Outsourcing medical affairs provides corporations cost-effective and flexible solution to address the budding issues and demands faced by the business. The regulatory setting is becoming rough due to amplified association among global regulatory bodies. As an outcome, compensations and drug approval need companies’ medical affairs to gather snowballing amounts of complicated, real-life patient outcomes data to establish product value.

Several countries are progressively intensifying their R&D expenditure that has prompted expansion of innovative products in the market. With the cumulative stringency by the particular regulatory authorities globally, a rising partnership among clinical research organizations, the drug developers and contract manufacturing organizations has been perceived to alleviate risks. As CMOs and CROs assist the corporations into reduce risks, companies are able to emphasis on their fundamental dealings. Hence, escalating research and development activities plus patent expirations are considered to be major growth influencers driving the global medical affairs outsourcing market.

Market Scope

Report Highlights Details
Growth Rate from 2025 to 2034 CAGR of 7.18%
Market Size in 2025 USD 2.08 Billion
Market Size by 2034 USD 3.89 Billion
Base Year 2024
Forecast Period 2025 to 2034
Segments Covered Services, Industry and Region
Regional Scope North America, APAC, Europe, Latin America, MEAN, Rest of the World

Services Insights

Different medical services analyzed in this research report include medical monitoring, medical writing & publishing, medical information, medical science liaisons and others. Out of all these services, medical writing & publishing appeared as most promising segment and garnered maximum revenue share of 33.64% in 2024. Currently, plentiful of the big pharma corporations are subcontracting their clinical data management to specialized medical writing & publishing service suppliers. Demand for professional medical writers is projected to grow considerably due to escalating introduction of assorted pharma products in the market. As a result, augmented need for professional medical writers is projected as the crucial influencers for growth of medical writing & publishing market segment.

Medical Affairs Outsourcing Market Share, By Services, 2024 (%)

The Medical Science Liaisons (MSLs) services segment projected to record fastest developing growth rate during assessment period.These are medical specialists with cutting-edge scientific training and are experts in cooperating intricate medical data to a diversity of stakeholders. The biopharma business sector is concentrating on the core undertakings associated to drug development than non-core actions including medical affairs. In order to decreases pending and profit from professional medical affairs services, biopharmafrims are subcontracting these services to the CROs or contract research organizations. Biotechnology businesses are further continuing at a great pace and are anticipated to offer a resilient competition to mid-size pharma firms during next few years.

Global Medical Affairs Outsourcing Market Revenue, By Services, 2022-2024 (USD Million)

By Services 2022 2023 2024
Medical Writing & Publishing 564.37 607.61 654.62
Medical Monitoring 161.36 173.38 186.42
Medical Science Liaisons 329.72 338.41 347.58
Medical Information 443.24 471.52 501.94
Others 202.52 227.90 255.35

Industry Insights

Global medical affairs outsourcing market report assessed different end-use industries making most of these outsourcing services in this research report including biopharmaceutical, pharmaceutical, and medical devices among others.

Among these, pharmaceutical segment dominated the global market by accounting prominent share more than 52.86% of the total revenue generated by market in 2024. This growth is attributed to the growing demand of medical affairs service for the groundwork of drafts of fresh patents due to expiration of different existing patents.

Global Medical Affairs Outsourcing Market Revenue, By Industry, 2022-2024 (USD Million)

By Industry 2022 2023 2024
Pharmaceutical 898.33 961.40 1,029.61
Biopharmaceutical 228.76 245.56 263.76
Medical Devices 574.11 611.87 652.55

Medical Affairs Outsourcing Market Companies

  • ICON plc
  • Wuxi Clinical Development, Inc
  • Pharmaceutical Product Development, LLC
  • Ashfield Healthcare Communications
  • Indegene Inc.
  • IQVIA Holdings Inc
  • The Medical Affairs Company (TMAC)
  • SGS SA
  • Syneos Health Inc
  • ZEINCRO Group

Segments Covered in the Report

By Services

  • Medical Monitoring
  • Medical Writing & Publishing
  • Medical Information
  • Medical Science Liaisons
  • Others

By Industry

  • Medical Devices
  • Pharmaceutical
  • Biopharmaceutical

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Middle East & Africa
  • Latin America

For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com

Frequently Asked Questions

The global medical affairs outsourcing market size was valued at USD 1.95 billion in 2024 and is predicted to reach over USD 3.89 billion by 2034.

The global medical affairs outsourcing market is expected to grow at a CAGR of 7.18% over forecast period 2025 to 2034.

In 2024, medical writing & publishing appeared as most promising segment and garnered maximum revenue share of the total market

Pharmaceutical industry segment conquered the global market by accounting prominent share more than 52.86% of the total revenue generated by market in 2024.

Some of the major participants contending in the market arena are IQVIA Holdings Inc., The Medical Affairs Company (TMAC), Ashfield Healthcare Communications, Syneos Health Inc., ICON plc, ZEINCRO Group, Pharmaceutical Product Development, LLC, Wuxi Clinical Development, Inc., Indegene Inc and SGS SA.

Global medical affairs outsourcing market is propelled by escalating research and developments undertakings along with growing spending in the healthcare sector across the globe. Further rising emphasis on CROs and CMOs is supporting the market growth across different economies in the world.

North America occupied for the prominent revenue chunk of the total gathered by global medical affairs outsourcing market in 2024 across various segments.

Asia Pacific is projected to record the utmost compounded annual growth throughout the estimate period due to contributing factors such as accessibility of low-cost labor and intensifying cases of regulatory filings.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

Meet the Team

Deepa Pandey, one of our esteemed authors, plays a crucial role in shaping the high-quality content that defines our research reports. Deepa holds a Master's in Pharmacy with a specialization in Pharmaceutical Quality Assurance, equipping her with an in-depth understanding of the healthcare industry's regulatory, quality, and operational nuances. With 2+ years of experience in market research, Deepa has made

Learn more about Deepa Pandey

With over 14 years of experience, Aditi is the powerhouse responsible for reviewing every piece of data and content that passes through our research pipeline. She is not just an expert—she’s the linchpin that ensures the accuracy, relevance, and clarity of the insights we deliver. Aditi’s broad expertise spans multiple sectors, with a keen focus on ICT, automotive, and various other cross-domain industries.

Learn more about Aditi Shivarkar

Related Reports